| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/09/1993 | US5192264 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 03/09/1993 | CA1314229C Treatment of lipoprotein disorders associated with cholesterol metabolism |
| 03/09/1993 | CA1314219C Use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs |
| 03/07/1993 | WO1992004462A1 Pathogen-specific ctl therapy |
| 03/07/1993 | CA2089488A1 Pathogen-specific ctl therapy |
| 03/04/1993 | WO1993004164A1 Keratinocyte-derived conditioned medium as a source of growth factors |
| 03/04/1993 | WO1993003769A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 03/04/1993 | WO1993003768A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 03/04/1993 | WO1993003760A1 Sirs vaccine and diagnosis method |
| 03/04/1993 | WO1993003735A1 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 03/04/1993 | WO1993003730A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | WO1993003710A1 A method of making biocompatible capsules containing cells |
| 03/04/1993 | CA2116118A1 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 03/04/1993 | CA2115994A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | CA2115742A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 03/04/1993 | CA2115664A1 A method of making biocompatible capsules containing cells |
| 03/03/1993 | EP0530060A1 Medication based on neutralised sulphur derivatives |
| 03/03/1993 | EP0529962A2 Purified propolis-extract, and its preparation and uses |
| 03/03/1993 | EP0529659A2 Agent for forming spheroids of hepatocytes and process for culturing hepatocytes for formation of spheroids |
| 03/03/1993 | EP0528954A1 Human neuronal cell line |
| 03/03/1993 | EP0528949A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample. |
| 03/03/1993 | EP0528859A1 Oral vaccine comprising antigen surface-associated with red blood cells |
| 03/03/1993 | EP0528842A1 Methods of tissue implantation |
| 03/03/1993 | EP0527199A4 T-cell receptor variable transcripts as disease related markers |
| 03/03/1993 | EP0419501B1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 03/03/1993 | EP0388428B1 $i(IN VIVO) DELIVERY OF NEUROTRANSMITTERS BY IMPLANTED, ENCAPSULATED CELLS |
| 03/03/1993 | EP0364442B1 Therapeutical compositions against psoriasis |
| 03/03/1993 | EP0363400B1 Method and apparatus for preparing composite skin replacement |
| 03/03/1993 | EP0310639B1 Omega-3 fatty acids in traumatic injury treatment |
| 03/03/1993 | EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 03/02/1993 | US5190657 Interlocking textile web |
| 03/01/1993 | CA2077175A1 Agent for forming spheroids of hepatocytes and process for culturing hepatocytes for formation of spheroids |
| 02/25/1993 | DE4127570A1 Antimicrobial effects of human in-vitro keratinocyte cultures - useful in the treatment of second or third degree burns and of badly healing wounds |
| 02/24/1993 | EP0528615A1 Cribrostatins 1 and 2 |
| 02/24/1993 | EP0528034A1 Remedy for asthma |
| 02/24/1993 | EP0528033A1 White laver |
| 02/24/1993 | EP0527810A1 Methods and compositions for reversibly permeabilizing the blood brain barrier |
| 02/24/1993 | EP0502949A4 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 02/24/1993 | CN1069265A Process for purification of hematoidin |
| 02/24/1993 | CN1069180A Medical pillow having effect of blood pressure reducing |
| 02/23/1993 | US5188959 Used in adoptive immunotherapy |
| 02/23/1993 | US5188844 Oxidation and reduction to change dark color to light color compatible with human skin; useful ingrediants in sunscreen cosmetic formulations |
| 02/21/1993 | CA2076505A1 Lps-containing anti-withdrawal agents |
| 02/18/1993 | WO1993003142A1 Proliferation of hepatocyte precursors |
| 02/18/1993 | WO1993002737A1 Treatment for type ii diabetes |
| 02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/18/1993 | WO1993002690A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | WO1993002688A1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs |
| 02/18/1993 | WO1993002686A1 Gangliosides with immunosuppressive ceramide moieties |
| 02/18/1993 | WO1993002556A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | CA2115140A1 Proliferation of hepatocyte precursors |
| 02/18/1993 | CA2114797A1 Treatment for type ii diabetes |
| 02/18/1993 | CA2114647A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | CA2113990A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/17/1993 | EP0527199A1 T-cell receptor variable transcripts as disease related markers. |
| 02/16/1993 | US5187102 Treating blood sample with thrombin inhibitor which does not bind bivalent cations |
| 02/16/1993 | US5186945 Deactivation using glycyrrhizic triperpenoid compound |
| 02/16/1993 | US5186944 Therapeutic medicament for thrombosis |
| 02/16/1993 | CA1313618C Lyophilization of red blood cells |
| 02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
| 02/10/1993 | EP0526550A1 Composite living skin equivalents |
| 02/10/1993 | CN2126802Y Culture box for seminal fluid |
| 02/09/1993 | US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk |
| 02/09/1993 | US5185160 Platelet membrane microvesicles |
| 02/09/1993 | CA2074701A1 Cribrostatins 1 and 2 |
| 02/09/1993 | CA2074699A1 Neristatin 1 |
| 02/04/1993 | WO1993002203A1 Fr901451 substance, process for preparation thereof and use thereof |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002182A1 Yolk sac stem cells |
| 02/04/1993 | DE4125024A1 Arzneimittel auf pflanzlicher basis zur tonuserhoehung und zur tonusmodulierung der glatt muskulaeren organe Medicinal plant-based to an increase in tone and tonusmodulierung smooth muscle organs |
| 02/04/1993 | CA2113555A1 Yolk sac stem cells |
| 02/03/1993 | EP0526258A2 A87689 Compounds, their production and use as phospholipase-A2 inhibitors |
| 02/03/1993 | EP0525138A1 A device for eradicating contaminants in fluids |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/03/1993 | CN1068495A Burn curing ointment and preparing process |
| 02/02/1993 | US5183807 Use of monosialoganglioside gm, to prevent the development of tolerance to the analgesic effect of morphine and related drugs |
| 02/02/1993 | US5183667 Treating tumor disease by administering culture product containing beta-glucan |
| 02/02/1993 | CA2075163A1 A87689 compounds |
| 01/27/1993 | EP0524834A2 Immunosuppressive drugs containing a cysteine protease |
| 01/27/1993 | EP0524803A2 Thromboplastin extract, reagent, and preparation thereof |
| 01/27/1993 | EP0524796A1 Use of essential fatty acids in the preparation of a medicament for the treatment of AIDS |
| 01/27/1993 | EP0524732A2 Composition containing lactic acid bacteria for preventing dental caries |
| 01/27/1993 | EP0524681A1 Process for the purification of serum albumin |
| 01/27/1993 | CN1068251A Production process of compound gynostemma pentaphylla tea |
| 01/26/1993 | WO1993001823A1 Intestine colonizing lactobacilli |
| 01/26/1993 | US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them |
| 01/26/1993 | US5182257 Anticarcinogenic agents |
| 01/26/1993 | US5182111 In vivo delivery of active factors by co-cultured cell implants |
| 01/26/1993 | CA1313142C Therapeutic hypertonic seawater solution |
| 01/25/1993 | CA2073913A1 Preparation of fatty acid medicaments |
| 01/23/1993 | WO1993001880A1 Blood filter and method of filtration |
| 01/21/1993 | WO1993001280A1 Inhibition of proton pump in osteoclast cells |
| 01/21/1993 | WO1993001275A1 NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
| 01/21/1993 | WO1993001241A1 Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained |
| 01/21/1993 | WO1993001207A1 Process for the purification of serum albumin |
| 01/21/1993 | WO1993000940A1 Apparatus for delivering drugs into red blood corpuscles |
| 01/21/1993 | WO1993000918A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/21/1993 | WO1993000822A1 Destruction of gram negative bacteria |
| 01/21/1993 | WO1992007656A3 System and method for processing biological fluids |